Skip to main content
. 2021 Mar 26;8(3):255–266. doi: 10.4103/apjon.apjon-2075

Table 3.

Problems experienced during or after chemotherapy (n=90)

Problem Exercise group (n=30), n (%) Cold application group (n=30), n (%) Control group (n=30), n (%) Total (n=90), n (%)
Dizziness 3 (10.0) 2 (6.7) 3 (10.0) 8 (8.9)
Loss of balance 3 (10.0) 2 (6.7) 1 (3.3) 6 (6.7)
Fall 1 (3.3) 0 0 1 (1.1)
Cold sensitivity 9 (30.0) 5 (16.7) 4 (13.3) 18 (20.0)
Tingle 27 (90.0) 23 (76.7) 25 (83.3) 75 (83.3)
Numbness 22 (73.3) 16 (53.3) 13 (43.3) 51 (56.7)
Burning 5 (16.7) 4 (13.3) 9 (30.0) 18 (20.0)
Swallowing difficulty 2 (6.7) 0 0 2 (2.2)
Weakness 18 (60.0) 13 (43.3) 15 (50.0) 46 (51.1)